Literature DB >> 22082706

Cognitive behavior therapy, exercise, or both for treating chronic widespread pain.

John McBeth1, Gordon Prescott, Graham Scotland, Karina Lovell, Philip Keeley, Phil Hannaford, Paul McNamee, Deborah P M Symmons, Steve Woby, Chrysa Gkazinou, Marcus Beasley, Gary J Macfarlane.   

Abstract

BACKGROUND: The clinical impact of telephone-delivered cognitive behavioral therapy (TCBT), exercise, or a combined intervention in primary care patients with chronic widespread pain (CWP) is unclear.
METHODS: A total of 442 patients with CWP (meeting the American College of Rheumatology criteria) were randomized to receive 6 months of TCBT, graded exercise, combined intervention, or treatment as usual (TAU). The primary outcome, using a 7-point patient global assessment scale of change in health since trial enrollment (range: very much worse to very much better), was assessed at baseline and 6 months (intervention end) and 9 months after randomization. A positive outcome was defined as "much better" or "very much better." Data were analyzed using logistic regression according to the intention-to-treat principle.
RESULTS: The percentages reporting a positive outcome at 6 and 9 months, respectively, were TAU group, 8% and 8%; TCBT group, 30% and 33%; exercise group, 35% and 24%; and combined intervention group, 37% and 37% (P < .001). After adjustment for age, sex, center, and baseline predictors of outcome, active interventions improved outcome compared with TAU: TCBT (6 months: odds ratio [OR], 5.0 [95% CI, 2.0-12.5]; 9 months: OR, 5.4 [95% CI, 2.3-12.8]), exercise (6 months: OR, 6.1 [95% CI, 2.5-15.1]; 9 months: OR, 3.6 [95% CI, 1.5-8.5]), and combined intervention (6 months: OR, 7.1 [95% CI, 2.9-17.2]; 9 months: OR, 6.2 [95% CI, 2.7-14.4]). At 6 and 9 months, combined intervention was associated with improvements in the 36-Item Short Form Health Questionnaire physical component score and a reduction in passive coping strategies. Conclusions on cost-effectiveness were sensitive to missing data.
CONCLUSION: TCBT was associated with substantial, statistically significant, and sustained improvements in patient global assessment. TRIAL REGISTRATION: clinicaltrials.gov Identifier: ISRCTN67013851.

Entities:  

Mesh:

Year:  2011        PMID: 22082706     DOI: 10.1001/archinternmed.2011.555

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  40 in total

1.  Exploratory Investigation of a Brief Cognitive Behavioral Intervention and Transcranial Direct Current Stimulation on Odor Sensitivity.

Authors:  David C Houghton; Thomas W Uhde; Jeffrey J Borckardt; Bernadette M Cortese
Journal:  Psychosom Med       Date:  2019-05       Impact factor: 4.312

2.  The epidemiology of regional and widespread musculoskeletal pain in rural versus urban settings in those ≥55 years.

Authors:  Rachael E Docking; Marcus Beasley; Artur Steinerowski; Elizabeth A Jones; Jane Farmer; Gary J Macfarlane; Gareth T Jones
Journal:  Br J Pain       Date:  2015-05

3.  Pain Coping Skills Training for Patients Who Catastrophize About Pain Prior to Knee Arthroplasty: A Multisite Randomized Clinical Trial.

Authors:  Daniel L Riddle; Francis J Keefe; Dennis C Ang; James Slover; Mark P Jensen; Matthew J Bair; Kurt Kroenke; Robert A Perera; Shelby D Reed; Daphne McKee; Levent Dumenci
Journal:  J Bone Joint Surg Am       Date:  2019-02-06       Impact factor: 5.284

Review 4.  Psychological Treatments and Psychotherapies in the Neurorehabilitation of Pain: Evidences and Recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation.

Authors:  Gianluca Castelnuovo; Emanuele M Giusti; Gian Mauro Manzoni; Donatella Saviola; Arianna Gatti; Samantha Gabrielli; Marco Lacerenza; Giada Pietrabissa; Roberto Cattivelli; Chiara A M Spatola; Stefania Corti; Margherita Novelli; Valentina Villa; Andrea Cottini; Carlo Lai; Francesco Pagnini; Lorys Castelli; Mario Tavola; Riccardo Torta; Marco Arreghini; Loredana Zanini; Amelia Brunani; Paolo Capodaglio; Guido E D'Aniello; Federica Scarpina; Andrea Brioschi; Lorenzo Priano; Alessandro Mauro; Giuseppe Riva; Claudia Repetto; Camillo Regalia; Enrico Molinari; Paolo Notaro; Stefano Paolucci; Giorgio Sandrini; Susan G Simpson; Brenda Wiederhold; Stefano Tamburin
Journal:  Front Psychol       Date:  2016-02-19

5.  Can the QuickDASH PROM be Altered by First Completing the Tasks on the Instrument?

Authors:  Lauren M Shapiro; Alex H S Harris; Sara L Eppler; Robin N Kamal
Journal:  Clin Orthop Relat Res       Date:  2019-09       Impact factor: 4.176

6.  Randomized Controlled Trial of Telephone-delivered Cognitive Behavioral Therapy Versus Supportive Care for Chronic Back Pain.

Authors:  Thomas Rutledge; J Hampton Atkinson; Tatiana Chircop-Rollick; John D'Andrea; Steven Garfin; Shetal Patel; Donald B Penzien; Mark Wallace; Anne L Weickgenant; Mark Slater
Journal:  Clin J Pain       Date:  2018-04       Impact factor: 3.442

7.  Sleep and physical activity: a cross-sectional objective profile of people with rheumatoid arthritis.

Authors:  Sean McKenna; Marie Tierney; Aoife O'Neill; Alexander Fraser; Norelee Kennedy
Journal:  Rheumatol Int       Date:  2018-03-14       Impact factor: 2.631

8.  Knee pain during daily tasks, knee osteoarthritis severity, and widespread pain.

Authors:  Daniel L Riddle; Paul W Stratford
Journal:  Phys Ther       Date:  2013-11-14

9.  Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.

Authors:  Joanna Leaviss; Sarah Davis; Shijie Ren; Jean Hamilton; Alison Scope; Andrew Booth; Anthea Sutton; Glenys Parry; Marta Buszewicz; Rona Moss-Morris; Peter White
Journal:  Health Technol Assess       Date:  2020-09       Impact factor: 4.014

10.  Comparing the association of widespread pain, multi-joint pain and low back pain with measures of pain sensitization and function in people with knee osteoarthritis.

Authors:  Olivier Guérard; Samuel Dufort; Laurence Forget Besnard; Alexis Gougeon; Lisa Carlesso
Journal:  Clin Rheumatol       Date:  2019-11-12       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.